KIMBERLY DIEHL: Open Payments
NPI 1265058374 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 16 payments from 13 companies in 2025. Trend: 2023 $777 · 2024 $327 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 1 | $85 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $36 |
| Celgene Corporation | 1 | $35 |
| Teleflex LLC | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Medtronic, Inc. | 1 | $22 |
| Boston Scientific Corporation | 2 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Merit Medical Systems Inc | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: COLLAGENASE SANTYL, NERLYNX, REBLOZYL, KEYTRUDA, INTERSTIM, QUIKCLOT, Axonics, Savi SCOUT.
Industry payments across SC — which companies pay providers there.
